Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kalvista Pharmaceuticals Inc (KALV)  
$11.92 0.15 (1.24%) as of 4:30 Fri 5/17


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 38,016,000
Market Cap: 453.15(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $7.58 - $16.04
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 23.7
Insider 3/6 Months : 24.3
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   KalVista Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. Co. has developed a proprietary portfolio of small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema. Co.'s primary focus is on developing oral plasma kallikrein inhibitors for HAE. Co. has developed its candidate sebetralstat into clinical development as a potential oral, on-demand therapy for HAE attacks. Co.'s oral product candidate, KVD824 is also being developed for potential prophylactic treatment of HAE.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,251,017 1,251,017 1,251,017
Total Buy Value $0 $16,112,140 $16,112,140 $16,112,140
Total People Bought 0 1 1 1
Total Buy Transactions 0 23 23 23
Total Shares Sold 102,326 397,465 463,546 511,543
Total Sell Value $1,442,962 $5,390,948 $6,095,847 $6,542,756
Total People Sold 5 5 6 6
Total Sell Transactions 5 19 25 46
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 277
  Page 11 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shah Rajeev M. Director   –       •      –    2016-11-21 4 A $0.00 $0 I/I 591,070 591,070     -
   Kolchinsky Peter 10% Owner   –       –       •   2016-11-21 4 A $0.00 $0 I/I 591,070 591,070     -
   Renzi David President & CEO   •       •      –    2016-11-21 4 D $8.59 $27,378 D/D (3,186) 0     -
   Renzi David President & CEO   •       •      –    2016-11-21 4 D $8.59 $287,477 D/D (33,454) 3,186     -
   Renzi David President & CEO   •       •      –    2016-11-21 4 OE $7.84 $287,258 D/D 36,640 36,640     -
   Basta Steven L Director   –       •      –    2016-11-21 4 D $8.59 $851 D/D (99) 0     -
   Basta Steven L Director   –       •      –    2016-11-21 4 D $8.59 $8,817 D/D (1,026) 99     -
   Basta Steven L Director   –       •      –    2016-11-21 4 OE $7.84 $8,820 D/D 1,125 1,125     -
   Maroney Marcee VP, Clinical Affairs   •       –      –    2016-11-21 4 D $8.59 $3,515 D/D (409) 0     -
   Maroney Marcee VP, Clinical Affairs   •       –      –    2016-11-21 4 D $8.59 $36,564 D/D (4,255) 409     -
   Maroney Marcee VP, Clinical Affairs   •       –      –    2016-11-21 4 OE $7.84 $36,566 D/D 4,664 4,664     -
   Renzi David President & CEO   •       •      –    2015-12-30 4 AS $3.70 $37,000 D/D (10,000) 0     -
   Renzi David President & CEO   •       •      –    2015-12-30 4 OE $0.56 $5,600 D/D 10,000 10,000     -
   Cha Albert Director   –       •      –    2015-04-14 4/A B $5.00 $5,062,500 I/I 1,012,500 4,204,562 2.1     -
   Cha Albert Director   –       •      –    2015-04-14 4/A A $0.00 $0 I/I 3,192,062 3,192,062     -
   Vivo Ventures Vi Affiilates Fund, L.p. 10% Owner   –       –       •   2015-04-14 4/A B $5.00 $5,062,500 I/I 1,012,500 4,204,562 1.5     -
   Vivo Ventures Vi Affiilates Fund, L.p. 10% Owner   –       –       •   2015-04-14 4/A A $0.00 $0 I/I 3,192,062 3,192,062     -
   Vivo Ventures Vi Affiilates Fund, L.p. 10% Owner   –       –       •   2015-04-14 4 B $5.00 $5,062,500 I/I 1,012,500 4,204,564 1.5     -
   Vivo Ventures Vi Affiilates Fund, L.p. 10% Owner   –       –       •   2015-04-14 4 A $0.00 $0 I/I 3,192,064 3,192,064     -
   Nasr Khaled 10% Owner   –       –       •   2015-04-14 4 B $5.00 $4,050,000 I/I 810,000 4,619,196 1.5     -
   Nasr Khaled 10% Owner   –       –       •   2015-04-14 4 A $0.00 $0 I/I 3,809,196 3,809,196     -
   Nohra Guy P Director   –       •      –    2015-04-14 4 B $5.00 $4,387,500 I/I 877,500 4,343,550 2.1     -
   Nohra Guy P Director   –       •      –    2015-04-14 4 A $0.00 $0 I/I 3,466,050 3,466,050     -
   Cha Albert Director   –       •      –    2015-04-14 4 B $5.00 $5,062,500 I/I 1,012,500 4,204,564 2.1     -
   Cha Albert Director   –       •      –    2015-04-14 4 A $0.00 $0 I/I 3,192,064 3,192,064     -
  277 Records found
  Previous  10  11  12   
  Page 11 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us